In every big pharma's life, a little Vioxx will fall. Yes, Merck
You don't get to be as big as Inside Value pick Pfizer
However, what is Merck worth these days? More importantly, is it really worth more or less than the market thinks? That is this week's question, as Brian Lawler and Ryan Fuhrmann can't see eye to eye when it comes to Merck.
- Read the bull argument
- Read the bear argument
- Read the bullish rebuttal
- Read the bearish rebuttal
- Sound off in Motley Fool CAPS
- Vote for the winner
Merck was also an Income Investor recommendation, until this past summer.